A detailed history of Slotnik Capital, LLC transactions in Catalent, Inc. stock. As of the latest transaction made, Slotnik Capital, LLC holds 283,500 shares of CTLT stock, worth $18 Million. This represents 5.69% of its overall portfolio holdings.

Number of Shares
283,500
Previous 195,500 45.01%
Holding current value
$18 Million
Previous $11 Billion 56.21%
% of portfolio
5.69%
Previous 5.33%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$56.16 - $60.96 $4.94 Million - $5.36 Million
88,000 Added 45.01%
283,500 $17.2 Billion
Q2 2024

Aug 14, 2024

BUY
$53.58 - $57.02 $857,280 - $912,320
16,000 Added 8.91%
195,500 $11 Billion
Q1 2024

May 15, 2024

BUY
$42.56 - $59.82 $7.64 Million - $10.7 Million
179,500 New
179,500 $10.1 Billion

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11.4B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Slotnik Capital, LLC Portfolio

Follow Slotnik Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Slotnik Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Slotnik Capital, LLC with notifications on news.